Eco-friendly novel deconvoluted synchronous spectrofluorimetric approach for the determination of favipiravir, levodropropizine and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in laboratory prepared mixtures and spiked human plasma

Eman A. Madbouly,Abdalla A. El-Shanawani,Sobhy M. El-adl,Ahmed S. Abdelkhalek
DOI: https://doi.org/10.1016/j.saa.2023.123823
IF: 4.831
2024-01-06
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
Abstract:In this work, a green, fast, and simple synchronous spectrofluorimetric approach has been developed to simultaneously determine favipiravir, levodropropizine, and moxifloxacin hydrochloride as co-administered medications for COVID-19 treatment in pure form and spiked human plasma. The synchronous fluorescence spectroscopy technique to analyze the studied drugs at ╬ö╬╗┬á=┬á110┬ánm enabled the determination of levodropropizine at 360┬ánm. Then, applying Fourier Self-Deconvolution to each spectra to measure favipiravir and moxifloxacin hydrochloride at peak amplitudes of 431┬ánm and 479┬ánm, respectively, without any interference. Favipiravir, levodropropizine, and moxifloxacin hydrochloride could be sensitively determined using the described approach over concentration ranges of 20ÔÇô300┬áng/mL, 10ÔÇô600┬áng/mL, and 50ÔÇô500┬áng/mL, respectively. The method's validation was carried out effectively in accordance with guidelines recommended by the ICH. Finally, the Eco-scale and Green Analytical Procedure Index (GAPI) techniques have been used to evaluate the greenness of the proposed method.
spectroscopy
What problem does this paper attempt to address?